Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.06 | $0 | -$158,035 |
| 2025 Q4 | 0.07 | $0 | — |
| 2025 Q3 | 0.08 | $0 | -$56,515 |
| 2025 Q2 | 0.08 | $0 | -$131,998 |
| 2025 Q1 | 0.07 | $0 | — |
| 2024 Q4 | 0.06 | $0 | -$89,687 |
| 2024 Q3 |
| -0.00 |
| $0 |
| $0 |